OKYO Pharma Limited
OKYO · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $50,150 | $43,134 | $37,392 | $54,532 |
| - Cash | $1,561 | $827 | $4,045 | $2,701 |
| + Debt | $0 | $0 | $2,215 | $0 |
| Enterprise Value | $48,589 | $42,307 | $35,561 | $51,831 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$3 | -$4 | -$4 | -$2 |
| % Margin | – | – | – | – |
| EBITDA | -$7,084 | -$15,746 | -$13,183 | -$6,215 |
| % Margin | – | – | – | – |
| Net Income | -$4,706 | -$16,825 | -$13,272 | -$5,431 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.001 | -0.6 | -0.36 |
| % Growth | -19,900% | 99.9% | -66.7% | – |
| Operating Cash Flow | -$1,811 | -$9,491 | -$7,695 | -$5,468 |
| Capital Expenditures | -$1 | $0 | -$6 | -$2 |
| Free Cash Flow | -$1,812 | -$9,491 | -$7,701 | -$5,470 |